Table 2

Echocardiographic parameters of RV size and systolic function on patients with a systemic RV and healthy volunteers

ParameterControl group (N = 38)All SRV patients (N = 38)TGA post-atrial switch repair (N = 24)ccTGA (N = 14)
Basal diameter, cm3.2 ± 0.45.5 ± 1.1; P < 0.00015.6 ± 1.05.3 ± 1.2; P = 0.432
Mid diameter, cm2.2 ± 0.35.1 ± 9.8; P < 0.00014.8 ± 7.05.6 ± 1.2; P = 0.017
Length, cm7.9 ± 0.67.9 ± 1.2; P = 0.8038.1 ± 1.17.6 ± 1.3; P = 0.149
EDAi, cm2/m214 ± 3.120 ± 5.1; P < 0.000121 ± 4.019 ± 6.4; P = 0.062
ESAi, cm2/m29 ± 1.915 ± 5.0; P < 0.000115 ± 4.914 ± 5.3; P = 0.498
FAC, %41 ± 427 ± 9; P < 0.000126 ± 8.828 ± 9.6; P = 0.486
TAPSE, mm25 ± 4.012 ± 4.2; P < 0.000111 ± 2.814 ± 5.4; P = 0.037
S′, cm/s15 ± 2.56.7 ± 2.3; P < 0.00016.3 ± 2.17.5 ± 2.7; P = 0.176
RV 4-chamber LS, %−22 ± 2.6−14 ± 3.2; P < 0.0001−13 ± 2.9−15 ± 3.4; P = 0.114
RV free wall LS, %−26 ± 3.8−15 ± 3.2; P < 0.0001−15 ± 2.8−16 ± 3.6; P = 0.165
3D EDVi, mL/m260 ± 12121 ± 43; P < 0.0001124 ± 30115 ± 61; P = 0.345
3D ESVi, mL/m230 ± 7.280 ± 38; P < 0.000183 ± 2775 ± 53; P = 0.161
3D EF, %60 ± 436 ± 8; P < 0.000134 ± 738 ± 9; P = 0.179
Components of RV EF
 LEF, %25 ± 4.612 ± 5.0; P < 0.000110 ± 3.315 ± 5.7; P < 0.0001
 REF, %30 ± 6.414 ± 5.9; P < 0.000113 ± 4.916 ± 7.1; P = 0.075
 AEF, %29 ± 4.216 ± 4.7; P < 0.000117 ± 4.514 ± 4.7; P = 0.171
 LEFi0.42 ± 0.080.33 ± 0.10; P = 0.00020.29 ± 0.080.41 ± 0.11; P = 0.0008
 REFi0.51 ± 0.090.39 ± 0.11; P < 0.00010.38 ± 0.100.41 ± 0.11; P = 0.370
 AEFi0.48 ± 0.060.44 ± 0.10; P = 0.0260.48 ± 0.090.36 ± 0.08; P = 0.0002
ParameterControl group (N = 38)All SRV patients (N = 38)TGA post-atrial switch repair (N = 24)ccTGA (N = 14)
Basal diameter, cm3.2 ± 0.45.5 ± 1.1; P < 0.00015.6 ± 1.05.3 ± 1.2; P = 0.432
Mid diameter, cm2.2 ± 0.35.1 ± 9.8; P < 0.00014.8 ± 7.05.6 ± 1.2; P = 0.017
Length, cm7.9 ± 0.67.9 ± 1.2; P = 0.8038.1 ± 1.17.6 ± 1.3; P = 0.149
EDAi, cm2/m214 ± 3.120 ± 5.1; P < 0.000121 ± 4.019 ± 6.4; P = 0.062
ESAi, cm2/m29 ± 1.915 ± 5.0; P < 0.000115 ± 4.914 ± 5.3; P = 0.498
FAC, %41 ± 427 ± 9; P < 0.000126 ± 8.828 ± 9.6; P = 0.486
TAPSE, mm25 ± 4.012 ± 4.2; P < 0.000111 ± 2.814 ± 5.4; P = 0.037
S′, cm/s15 ± 2.56.7 ± 2.3; P < 0.00016.3 ± 2.17.5 ± 2.7; P = 0.176
RV 4-chamber LS, %−22 ± 2.6−14 ± 3.2; P < 0.0001−13 ± 2.9−15 ± 3.4; P = 0.114
RV free wall LS, %−26 ± 3.8−15 ± 3.2; P < 0.0001−15 ± 2.8−16 ± 3.6; P = 0.165
3D EDVi, mL/m260 ± 12121 ± 43; P < 0.0001124 ± 30115 ± 61; P = 0.345
3D ESVi, mL/m230 ± 7.280 ± 38; P < 0.000183 ± 2775 ± 53; P = 0.161
3D EF, %60 ± 436 ± 8; P < 0.000134 ± 738 ± 9; P = 0.179
Components of RV EF
 LEF, %25 ± 4.612 ± 5.0; P < 0.000110 ± 3.315 ± 5.7; P < 0.0001
 REF, %30 ± 6.414 ± 5.9; P < 0.000113 ± 4.916 ± 7.1; P = 0.075
 AEF, %29 ± 4.216 ± 4.7; P < 0.000117 ± 4.514 ± 4.7; P = 0.171
 LEFi0.42 ± 0.080.33 ± 0.10; P = 0.00020.29 ± 0.080.41 ± 0.11; P = 0.0008
 REFi0.51 ± 0.090.39 ± 0.11; P < 0.00010.38 ± 0.100.41 ± 0.11; P = 0.370
 AEFi0.48 ± 0.060.44 ± 0.10; P = 0.0260.48 ± 0.090.36 ± 0.08; P = 0.0002

Data are presented as mean ± SD.

P (in All SRV) value indicates difference compared with the control group.

P (in ccTGA) value indicates difference compared with the TGA group.

EDAi, indexed end-diastolic area; EDVi, indexed end-diastolic volume; ESAi, indexed end-systolic area; ESVi, indexed end-systolic volume; LS, longitudinal strain.

Table 2

Echocardiographic parameters of RV size and systolic function on patients with a systemic RV and healthy volunteers

ParameterControl group (N = 38)All SRV patients (N = 38)TGA post-atrial switch repair (N = 24)ccTGA (N = 14)
Basal diameter, cm3.2 ± 0.45.5 ± 1.1; P < 0.00015.6 ± 1.05.3 ± 1.2; P = 0.432
Mid diameter, cm2.2 ± 0.35.1 ± 9.8; P < 0.00014.8 ± 7.05.6 ± 1.2; P = 0.017
Length, cm7.9 ± 0.67.9 ± 1.2; P = 0.8038.1 ± 1.17.6 ± 1.3; P = 0.149
EDAi, cm2/m214 ± 3.120 ± 5.1; P < 0.000121 ± 4.019 ± 6.4; P = 0.062
ESAi, cm2/m29 ± 1.915 ± 5.0; P < 0.000115 ± 4.914 ± 5.3; P = 0.498
FAC, %41 ± 427 ± 9; P < 0.000126 ± 8.828 ± 9.6; P = 0.486
TAPSE, mm25 ± 4.012 ± 4.2; P < 0.000111 ± 2.814 ± 5.4; P = 0.037
S′, cm/s15 ± 2.56.7 ± 2.3; P < 0.00016.3 ± 2.17.5 ± 2.7; P = 0.176
RV 4-chamber LS, %−22 ± 2.6−14 ± 3.2; P < 0.0001−13 ± 2.9−15 ± 3.4; P = 0.114
RV free wall LS, %−26 ± 3.8−15 ± 3.2; P < 0.0001−15 ± 2.8−16 ± 3.6; P = 0.165
3D EDVi, mL/m260 ± 12121 ± 43; P < 0.0001124 ± 30115 ± 61; P = 0.345
3D ESVi, mL/m230 ± 7.280 ± 38; P < 0.000183 ± 2775 ± 53; P = 0.161
3D EF, %60 ± 436 ± 8; P < 0.000134 ± 738 ± 9; P = 0.179
Components of RV EF
 LEF, %25 ± 4.612 ± 5.0; P < 0.000110 ± 3.315 ± 5.7; P < 0.0001
 REF, %30 ± 6.414 ± 5.9; P < 0.000113 ± 4.916 ± 7.1; P = 0.075
 AEF, %29 ± 4.216 ± 4.7; P < 0.000117 ± 4.514 ± 4.7; P = 0.171
 LEFi0.42 ± 0.080.33 ± 0.10; P = 0.00020.29 ± 0.080.41 ± 0.11; P = 0.0008
 REFi0.51 ± 0.090.39 ± 0.11; P < 0.00010.38 ± 0.100.41 ± 0.11; P = 0.370
 AEFi0.48 ± 0.060.44 ± 0.10; P = 0.0260.48 ± 0.090.36 ± 0.08; P = 0.0002
ParameterControl group (N = 38)All SRV patients (N = 38)TGA post-atrial switch repair (N = 24)ccTGA (N = 14)
Basal diameter, cm3.2 ± 0.45.5 ± 1.1; P < 0.00015.6 ± 1.05.3 ± 1.2; P = 0.432
Mid diameter, cm2.2 ± 0.35.1 ± 9.8; P < 0.00014.8 ± 7.05.6 ± 1.2; P = 0.017
Length, cm7.9 ± 0.67.9 ± 1.2; P = 0.8038.1 ± 1.17.6 ± 1.3; P = 0.149
EDAi, cm2/m214 ± 3.120 ± 5.1; P < 0.000121 ± 4.019 ± 6.4; P = 0.062
ESAi, cm2/m29 ± 1.915 ± 5.0; P < 0.000115 ± 4.914 ± 5.3; P = 0.498
FAC, %41 ± 427 ± 9; P < 0.000126 ± 8.828 ± 9.6; P = 0.486
TAPSE, mm25 ± 4.012 ± 4.2; P < 0.000111 ± 2.814 ± 5.4; P = 0.037
S′, cm/s15 ± 2.56.7 ± 2.3; P < 0.00016.3 ± 2.17.5 ± 2.7; P = 0.176
RV 4-chamber LS, %−22 ± 2.6−14 ± 3.2; P < 0.0001−13 ± 2.9−15 ± 3.4; P = 0.114
RV free wall LS, %−26 ± 3.8−15 ± 3.2; P < 0.0001−15 ± 2.8−16 ± 3.6; P = 0.165
3D EDVi, mL/m260 ± 12121 ± 43; P < 0.0001124 ± 30115 ± 61; P = 0.345
3D ESVi, mL/m230 ± 7.280 ± 38; P < 0.000183 ± 2775 ± 53; P = 0.161
3D EF, %60 ± 436 ± 8; P < 0.000134 ± 738 ± 9; P = 0.179
Components of RV EF
 LEF, %25 ± 4.612 ± 5.0; P < 0.000110 ± 3.315 ± 5.7; P < 0.0001
 REF, %30 ± 6.414 ± 5.9; P < 0.000113 ± 4.916 ± 7.1; P = 0.075
 AEF, %29 ± 4.216 ± 4.7; P < 0.000117 ± 4.514 ± 4.7; P = 0.171
 LEFi0.42 ± 0.080.33 ± 0.10; P = 0.00020.29 ± 0.080.41 ± 0.11; P = 0.0008
 REFi0.51 ± 0.090.39 ± 0.11; P < 0.00010.38 ± 0.100.41 ± 0.11; P = 0.370
 AEFi0.48 ± 0.060.44 ± 0.10; P = 0.0260.48 ± 0.090.36 ± 0.08; P = 0.0002

Data are presented as mean ± SD.

P (in All SRV) value indicates difference compared with the control group.

P (in ccTGA) value indicates difference compared with the TGA group.

EDAi, indexed end-diastolic area; EDVi, indexed end-diastolic volume; ESAi, indexed end-systolic area; ESVi, indexed end-systolic volume; LS, longitudinal strain.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close